Go Pro

ALX Oncology (ALXO) Institutional Ownership

ALX Oncology logo
$1.96 +0.02 (+1.03%)
Closing price 04:00 PM Eastern
Extended Trading
$1.94 -0.02 (-0.97%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for ALX Oncology (NASDAQ:ALXO)

Current
Institutional Ownership
Percentage
97.97%
Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$55.58M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.39M
Get ALXO Insider Trade Alerts

Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALXO Institutional Buying and Selling by Quarter

ALX Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/20265AM Venture Management LLC3,057,325$6.33B2.2%N/A2.211%
8/14/2026ADAR1 Capital Management LLC533,660$1.11M0.1%N/A0.386%
8/14/2026The Manufacturers Life Insurance Company 30,997$64K0.0%N/A0.022%
8/12/2026 Ieq Capital LLC175,382$363K0.0%N/A0.127%
8/12/2026 Callan Family Office LLC22,419$46K0.0%N/A0.016%
8/7/2026 BlackRock Inc.7,399,530$15.32M0.0%N/A5.499%
8/7/2026 Deutsche Bank AG107,428$222K0.0%N/A0.080%
8/6/2026 Bank of New York Mellon Corp238,447$494K0.0%N/A0.177%
8/6/2026 GSA Capital Partners LLP413,545$856K0.1%N/A0.307%
5/20/2026Vivo Capital LLC3,184,713$6.39M0.5%N/A2.367%
5/19/2026Bank of America Corp DE577,783$1.16M0.0%+8.6%0.429%
5/18/2026Redmile Group LLC7,964,188$15.97M1.1%+143.9%5.919%
5/16/2026venBio Partners LLC12,884,638$25.83M9.2%+32.8%9.575%
5/16/2026Orbimed Advisors LLC2,866,256$5.75M0.1%N/A2.130%
5/15/2026 OMERS ADMINISTRATION Corp75,000$150K0.0%N/A0.056%
5/14/2026 Renaissance Technologies LLC732,599$1.47M0.0%+73.2%0.544%
2/26/2026Seven Fleet Capital Management LP117,817$133K0.1%N/A0.217%
2/18/2026Bridgeway Capital Management LLC76,072$86K0.0%+111.3%0.140%
2/13/2026 Marshall Wace LLP26,376$30K0.0%-33.4%0.049%
2/13/2026 State Street Corp124,228$140K0.0%+11.0%0.229%
2/12/2026 Renaissance Technologies LLC423,099$478K0.0%+157.2%0.780%
1/1/2026 JPMorgan Chase & Co.61,899$113K0.0%-29.9%0.114%
11/17/2025Qube Research & Technologies Ltd16,946$31K0.0%-61.6%0.031%
11/17/2025Bank of America Corp DE530,828$971K0.0%-48.7%0.979%
11/17/2025Ameriprise Financial Inc.652,897$1.20M0.0%N/A1.204%
11/14/2025Two Sigma Investments LP606,671$1.11M0.0%+26.9%1.119%
11/14/2025Bridgeway Capital Management LLC36,000$66K0.0%N/A0.066%
11/7/2025Vanguard Group Inc.1,528,619$2.80M0.0%-4.5%2.855%
11/7/2025 JPMorgan Chase & Co.61,899$113K0.0%-29.9%0.116%
8/15/2025Bank of America Corp DE1,035,127$430K0.0%-28.7%1.933%
8/14/2025Jane Street Group LLC203,266$84K0.0%N/A0.381%
8/14/2025Redmile Group LLC3,391,455$1.41M0.1%-6.8%6.352%
8/13/2025 Marshall Wace LLP106,280$45K0.0%-60.8%0.199%
8/12/2025XTX Topco Ltd74,770$31K0.0%-19.0%0.140%
8/12/2025 JPMorgan Chase & Co.88,352$37K0.0%-75.3%0.165%
8/8/2025 Geode Capital Management LLC315,421$131K0.0%-59.1%0.591%
6/27/2025Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699%
5/21/2025Acadian Asset Management LLC1,296,331$806K0.0%+16.8%2.428%
5/16/2025Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699%
5/16/2025AQR Capital Management LLC119,050$74K0.0%+183.6%0.223%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
5/16/2025Almitas Capital LLC1,353,141$843K0.3%+10.6%2.534%
5/15/2025Redmile Group LLC3,640,834$2.27M0.2%-1.3%6.819%
5/15/2025MPM Bioimpact LLC550,000$343K0.1%-60.5%1.030%
5/12/2025Nuveen LLC164,790$103K0.0%N/A0.309%
5/12/2025Invesco Ltd.73,836$46K0.0%N/A0.138%
5/8/2025XTX Topco Ltd92,259$57K0.0%-65.0%0.173%
2/17/2025Two Sigma Investments LP704,131$1.18M0.0%+6.7%1.335%
2/17/2025Two Sigma Advisers LP823,900$1.38M0.0%+64.6%1.562%
2/17/2025Tang Capital Management LLC3,296,883$5.51M0.4%-21.6%6.251%
2/17/2025Redmile Group LLC3,689,611$6.16M0.4%-3.8%6.996%
2/17/2025MPM Bioimpact LLC1,391,434$2.32M0.3%-42.3%2.638%
2/17/2025Nuveen Asset Management LLC164,790$275K0.0%+55.6%0.312%
2/17/2025Deutsche Bank AG101,113$169K0.0%+521.0%0.192%
2/17/2025D. E. Shaw & Co. Inc.255,878$427K0.0%-11.9%0.485%
2/17/2025Cubist Systematic Strategies LLC32,021$53K0.0%-91.7%0.061%
2/17/2025Bridgeway Capital Management LLC75,000$125K0.0%N/A0.142%
2/17/2025Bank of America Corp DE1,035,326$1.73M0.0%+492.9%1.963%
2/17/2025Almitas Capital LLC1,222,945$2.04M0.4%N/A2.319%
2/14/2025Northern Trust Corp343,066$573K0.0%+7.3%0.650%
2/14/2025Dimensional Fund Advisors LP26,233$44K0.0%-30.3%0.050%
2/13/2025XTX Topco Ltd263,856$441K0.0%-16.8%0.500%
2/13/2025Bank of Nova Scotia105,306$176K0.0%N/A0.200%
2/13/2025Bank of Montreal Can826,582$1.38M0.0%N/A1.567%
2/12/2025Geode Capital Management LLC740,106$1.24M0.0%+5.6%1.403%
2/12/2025JPMorgan Chase & Co.236,046$394K0.0%+476.7%0.448%
2/11/2025Sei Investments Co.60,795$102K0.0%N/A0.115%
2/6/2025Charles Schwab Investment Management Inc.216,707$362K0.0%-3.8%0.411%
2/4/2025Los Angeles Capital Management LLC301,419$503K0.0%+16.9%0.572%
2/4/2025Bank of New York Mellon Corp90,003$150K0.0%+12.0%0.171%
1/29/2025JSF Financial LLC17,500$29K0.0%N/A0.033%
11/19/2024Barclays PLC59,502$107K0.0%+243.6%0.113%
11/15/2024Barclays PLC59,502$107K0.0%+243.6%0.113%
11/15/2024XTX Topco Ltd317,322$578K0.0%N/A0.602%
11/15/2024Jane Street Group LLC27,918$51K0.0%-64.3%0.053%
11/15/2024Wellington Management Group LLP167,831$305K0.0%+15.2%0.318%
11/15/2024State Street Corp671,376$1.22M0.0%-4.8%1.273%
11/15/2024Redmile Group LLC3,836,576$6.98M0.4%-5.0%7.274%
11/14/2024Verition Fund Management LLC133,025$242K0.0%+308.4%0.252%
11/14/2024Walleye Capital LLC230,875$420K0.0%+110.3%0.438%
11/13/2024FMR LLC5,865,106$10.67M0.0%-25.0%11.121%
11/12/2024Charles Schwab Investment Management Inc.225,302$410K0.0%-4.5%0.428%
11/8/2024Connor Clark & Lunn Investment Management Ltd.83,042$151K0.0%+207.4%0.158%
11/5/2024GSA Capital Partners LLP48,204$88K0.0%N/A0.092%
11/4/2024Los Angeles Capital Management LLC257,779$469K0.0%N/A0.489%
11/2/2024Privium Fund Management B.V.509,059$926K0.2%+28.2%0.967%
10/3/2024SG Americas Securities LLC27,394$50K0.0%+33.6%0.053%
8/19/2024Point72 Asset Management L.P.304,100$1.83M0.0%N/A0.584%
8/16/2024Algert Global LLC41,215$249K0.0%N/A0.079%
8/15/2024Susquehanna Portfolio Strategies LLC73,468$443K0.0%-19.2%0.141%
8/15/2024The Manufacturers Life Insurance Company13,662$82K0.0%-77.3%0.026%
Buy These Stocks Before August 31st (Ad)

Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwide. The analyst, who called the 2020 crash early, is working with a former NSA codebreaker and Pentagon insider on a new approach to AI stocks ahead of August 31. Investors like Stephen and Keith W. say the tools helped shape their portfolios, though results vary and are not typical.tc pixel

Get the full details on Keith Kaplan's AI stock research now
8/15/2024AQR Capital Management LLC18,079$109K0.0%+50.7%0.035%
8/14/2024Cubist Systematic Strategies LLC199,441$1.20M0.0%N/A0.383%
8/14/2024Marshall Wace LLP635,679$3.83M0.0%+423.0%1.220%
8/12/2024Inspire Investing LLC58,707$354K0.0%+77.1%0.113%
8/12/2024Hsbc Holdings PLC10,780$63K0.0%N/A0.021%
8/9/2024Renaissance Technologies LLC438,200$2.64M0.0%+87.2%0.841%
8/9/2024Dimensional Fund Advisors LP34,543$208K0.0%-31.4%0.066%
8/8/2024American Century Companies Inc.23,685$143K0.0%-20.2%0.045%
8/6/2024Quest Partners LLC20,781$125K0.0%-17.0%0.040%
8/1/2024Rhumbline Advisers55,220$333K0.0%+10.8%0.106%


ALXO Institutional Ownership - Frequently Asked Questions

During the previous two years, 59 institutional investors and hedge funds held shares of ALX Oncology. The most heavily invested institutionals were 5AM Venture Management LLC ($6.33B), venBio Partners LLC ($25.83M), Redmile Group LLC ($15.97M), BlackRock Inc. ($15.32M), FMR LLC ($10.67M), Vivo Capital LLC ($6.39M), and Orbimed Advisors LLC ($5.75M).Learn more on ALX Oncology's institutional investors.

97.97% of ALX Oncology's stock is owned by institutional investors. Learn more on ALXO's institutional investor holdings.

Of the 49 institutional investors that purchased ALX Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($7.40M), Redmile Group LLC ($4.70M), venBio Partners LLC ($3.18M), Vivo Capital LLC ($3.18M), 5AM Venture Management LLC ($3.06M), Orbimed Advisors LLC ($2.87M), and Almitas Capital LLC ($1.35M).

Institutional investors have bought a total of 27,590,746 shares in the last 24 months. This purchase volume represents approximately $55.58M in transactions.

The following institutional investors have sold ALX Oncology stock in the last 24 months: Bank of America Corp DE ($920.95K), Vanguard Group Inc. ($72.19K), JPMorgan Chase & Co. ($52.91K), Qube Research & Technologies Ltd ($27.19K), and Marshall Wace LLP ($13.21K).

Institutional investors have sold a total of 1,086,439 shares in the last 24 months. This volume of shares sold represents approximately $1.39M in transactions.



Institutional ownership data for NASDAQ:ALXO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners